We also confirmed these findings by GSEA of ANXA2-inhibited GBM cells, which shows a significant negative enrichment of gene signatures associated to undifferentiated cancer and stem cell phenotype (Figure 2B), suggesting the potential involvement of ANXA2 also as a modulator of differentiation in GBM cells. The gene discussed is ANXA2; the disease is cancer.